Your browser doesn't support javascript.
loading
Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design.
Santacana, Eugènia; Rodríguez-Alonso, Lorena; Padullés, Ariadna; Guardiola, Jordi; Bas, Jordi; Rodríguez-Moranta, Francisco; Serra, Katja; Morandeira, Francisco; Colom, Helena; Padullés, Núria.
Affiliation
  • Santacana E; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB, Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat.
  • Rodríguez-Alonso L; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB, L'Hospitalet de Llobregat.
  • Padullés A; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB, Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat.
  • Guardiola J; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB, L'Hospitalet de Llobregat.
  • Bas J; Immunology, Hospital Universitari de Bellvitge-HUB, L'Hospitalet de Llobregat; and.
  • Rodríguez-Moranta F; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB, L'Hospitalet de Llobregat.
  • Serra K; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB, L'Hospitalet de Llobregat.
  • Morandeira F; Immunology, Hospital Universitari de Bellvitge-HUB, L'Hospitalet de Llobregat; and.
  • Colom H; Pharmacy and Pharmaceutical Technology Department, Universitat de Barcelona-UB, Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Padullés N; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB, Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat.
Ther Drug Monit ; 42(1): 102-110, 2020 02.
Article in En | MEDLINE | ID: mdl-31283556
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Drug Monitoring / Infliximab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ther Drug Monit Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Drug Monitoring / Infliximab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ther Drug Monit Year: 2020 Document type: Article